UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 689

Sortiert nach

Self‐reported prevalence, description and management of pain in adults with haemophilia: methods, demographics and results from the Pain, Functional Impairment, and Quality of life (P‐FiQ) study

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-07, Vol.23 (4), p.556-565

2017

Volltextzugriff (PDF)

Impact of pain and functional impairment in US adults with haemophilia: Patient‐reported outcomes and musculoskeletal evaluation in the pain, functional impairment and quality of life (P‐FiQ) study

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-03, Vol.24 (2), p.261-270

2018

Volltextzugriff (PDF)

Dosing and effectiveness of recombinant activated factor VII (rFVIIA) in congenital haemophilia with inhibitors by bleed type and location: the experience of the Haemophilia and Thrombosis Research Society (HTRS) Registry (2004-2008)

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-11, Vol.18 (6), p.990-996

2012

Volltextzugriff (PDF)

Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief

Climacteric : the journal of the International Menopause Society, 2007-04, Vol.10 (2), p.120-131

2007

Volltextzugriff (PDF)

US experience with recombinant factor VIIa for surgery and other invasive procedures in acquired haemophilia: analysis from the Hemostasis and Thrombosis Research Society Registry

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-01, Vol.22 (1), p.e18-e24

2016

Volltextzugriff (PDF)

Safety of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors: overall rFVIIa exposure and intervals following high (>240 μg kg−1) rFVIIa doses across clinical trials and registries

Haemophilia : the official journal of the World Federation of Hemophilia, 2014-01, Vol.20 (1), p.e23-e31

2014

Volltextzugriff (PDF)

Patient/Caregiver-reported recombinant factor VIIa (rFVIIa) dosing: home treatment of acute bleeds in the Dosing Observational Study in Hemophilia (DOSE)

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-05, Vol.18 (3), p.392-399

2012

Volltextzugriff (PDF)

P01-48 Pediatric patients with Prader-Willi syndrome are responders to growth hormone treatment: Analysis of 3-year data from the ANSWER Program

Growth hormone & IGF research, 2012-10, Vol.22, p.S49-S49

2012

Volltextzugriff (PDF)

High-precision EMG signal decomposition using communication techniques

IEEE transactions on signal processing, 2000-09, Vol.48 (9), p.2487-2494

2000

Volltextzugriff (PDF)

An ultra-low dose (10μg) estradiol vaginal tablet improves signs and symptoms associated with vaginal atrophy

Fertility and sterility, 2008-09, Vol.90, p.S250-S250

2008

Volltextzugriff (PDF)

US experience with recombinant factor VII a for surgery and other invasive procedures in acquired haemophilia: analysis from the Hemostasis and Thrombosis Research Society Registry

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-01, Vol.22 (1)

2016

Volltextzugriff (PDF)

Assessment of acquired hemophilia patient demographics in the United States: the Hemostasis and Thrombosis Research Society Registry

Blood coagulation & fibrinolysis, 2016-10, Vol.27 (7), p.761-769

2016

Volltextzugriff (PDF)

Five-Year Audit of Ambulatory 24-Hour Esophageal pH-Manometry in Clinical Practice

Scandinavian journal of gastroenterology, 1999, Vol.34 (7), p.676-682

1999

Volltextzugriff (PDF)

Safety of recombinant activated factor VII ( rFVII a) in patients with congenital haemophilia with inhibitors: overall rFVII a exposure and intervals following high (>240 μg kg −1 ) rFVII a doses across clinical trials and registries

Haemophilia : the official journal of the World Federation of Hemophilia, 2014-01, Vol.20 (1)

2014

Volltextzugriff (PDF)

Adrenal hypoplasia congenita – an uncommon reason of primary adrenal insufficiency

Annales d'endocrinologie, 2010-09, Vol.71 (4), p.309-313

2010

Volltextzugriff (PDF)

A simplified model for kinetics of a tumor cells' population

Voprosy onkologij, 2009, Vol.55 (1), p.83

2009

Volltextzugriff (PDF)

PSY46 EFFECT OF ACUTE BLEEDING EPISODES ON QUALITY OF LIFE (QOL) IN PATIENTS WITH CONGENITAL HEMOPHILIA WITH INHIBITORS (CHWI) AND THEIR FAMILIES: OBSERVATIONS OF BLEED VS. NON-BLEED DAY QOL FROM THE DOSING OBSERVATIONAL STUDY IN HEMOPHILIA (DOSE) AND IMPLICATIONS FOR ASSESSMENT AND PREDICTION

Value in health, 2010, Vol.13 (3), p.A214-A214

2010

Volltextzugriff (PDF)

PSY45 IMPACT OF ACUTE BLEEDING AND ADMINISTRATION OF BYPASSING AGENTS (BPA) ON DAILY ACTIVITIES OF PATIENTS WITH CONGENITAL HEMOPHILIA WITH INHIBITORS (CHWI) AND THEIR CAREGIVERS AND FAMILIES: OBSERVATIONS FROM THE DOSING OBSERVATIONAL STUDY IN HEMOPHILIA (DOSE)

Value in health, 2010, Vol.13 (3), p.A214-A214

2010

Volltextzugriff (PDF)

A novel supplemental approach to capturing post-marketing safety information on recombinant factor VIIa in acquired hemophilia: the Acquired Hemophilia Surveillance project

Journal of blood medicine, 2014-01, Vol.5 (default), p.1-3

2014

Volltextzugriff (PDF)

Zur Polarographie von Niob und Tantal

Helvetica chimica acta, 1960, Vol.43 (3), p.830-842

Gut, R.

1960

Volltextzugriff (PDF)

Clinical leaders' and staff's assessment of the current quality related to the patient pathways and expectations of and knowledge about accreditation--a baseline evaluation in Copenhagen County

Ugeskrift for læger, 2006-11, Vol.168 (46), p.3993

2006

Volltextzugriff (PDF)

The structure of H3O+TiF5

Journal of fluorine chemistry, 1982-05, Vol.20 (3), p.349-356

1982

Volltextzugriff (PDF)

The phosphonium - sulfonium - and arsonium — salts of TaF6− and Ta2F11

Inorganic & nuclear chemistry letters, 1976-01, Vol.12 (2), p.149-152

Gut, R.

1976

Volltextzugriff (PDF)

Capturing daily assessments and home treatment of congenital hemophilia with inhibitors: design, disposition, and implications of the Dosing Observational Study in Hemophilia (DOSE)

Journal of blood medicine, 2012-01, Vol.3 (default), p.131-138

2012

Volltextzugriff (PDF)

1 – 25 von 689

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(602)
Mit Volltextzugriff
(615)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(420)
Life Sciences & Biomedicine
(327)
Humans
(244)
Male
(157)
Animals
(152)
Female
(145)
Biological And Medical Sciences
(126)
Fundamental And Applied Biological Sciences. Psychology
(71)
Medical Sciences
(68)
Middle Aged
(64)
Adult
(63)
Biochemistry & Molecular Biology
(52)
Physical Sciences
(50)
Chemistry
(48)
Life Sciences
(48)
Pharmacology & Pharmacy
(48)
Entomology
(46)
Aged
(42)
Multidisciplinary Sciences
(41)
Science & Technology - Other Topics
(41)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Self‐reported prevalence, description and management of pain in adults with haemophilia: methods, demographics and results from the Pain, Functional Impairment, and Quality of life (P‐FiQ) study

Impact of pain and functional impairment in US adults with haemophilia: Patient‐reported outcomes and musculoskeletal evaluation in the pain, functional impairment and quality of life (P‐FiQ) study

Dosing and effectiveness of recombinant activated factor VII (rFVIIA) in congenital haemophilia with inhibitors by bleed type and location: the experience of the Haemophilia and Thrombosis Research Society (HTRS) Registry (2004-2008)

Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief

US experience with recombinant factor VIIa for surgery and other invasive procedures in acquired haemophilia: analysis from the Hemostasis and Thrombosis Research Society Registry

Safety of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors: overall rFVIIa exposure and intervals following high (>240 μg kg−1) rFVIIa doses across clinical trials and registries

Patient/Caregiver-reported recombinant factor VIIa (rFVIIa) dosing: home treatment of acute bleeds in the Dosing Observational Study in Hemophilia (DOSE)

Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B

P01-48 Pediatric patients with Prader-Willi syndrome are responders to growth hormone treatment: Analysis of 3-year data from the ANSWER Program

High-precision EMG signal decomposition using communication techniques

An ultra-low dose (10μg) estradiol vaginal tablet improves signs and symptoms associated with vaginal atrophy

US experience with recombinant factor VII a for surgery and other invasive procedures in acquired haemophilia: analysis from the Hemostasis and Thrombosis Research Society Registry

Assessment of acquired hemophilia patient demographics in the United States: the Hemostasis and Thrombosis Research Society Registry

Five-Year Audit of Ambulatory 24-Hour Esophageal pH-Manometry in Clinical Practice

Safety of recombinant activated factor VII ( rFVII a) in patients with congenital haemophilia with inhibitors: overall rFVII a exposure and intervals following high (>240 μg kg −1 ) rFVII a doses across clinical trials and registries

Adrenal hypoplasia congenita – an uncommon reason of primary adrenal insufficiency

A simplified model for kinetics of a tumor cells' population

PSY46 EFFECT OF ACUTE BLEEDING EPISODES ON QUALITY OF LIFE (QOL) IN PATIENTS WITH CONGENITAL HEMOPHILIA WITH INHIBITORS (CHWI) AND THEIR FAMILIES: OBSERVATIONS OF BLEED VS. NON-BLEED DAY QOL FROM THE DOSING OBSERVATIONAL STUDY IN HEMOPHILIA (DOSE) AND IMPLICATIONS FOR ASSESSMENT AND PREDICTION

PSY45 IMPACT OF ACUTE BLEEDING AND ADMINISTRATION OF BYPASSING AGENTS (BPA) ON DAILY ACTIVITIES OF PATIENTS WITH CONGENITAL HEMOPHILIA WITH INHIBITORS (CHWI) AND THEIR CAREGIVERS AND FAMILIES: OBSERVATIONS FROM THE DOSING OBSERVATIONAL STUDY IN HEMOPHILIA (DOSE)

A novel supplemental approach to capturing post-marketing safety information on recombinant factor VIIa in acquired hemophilia: the Acquired Hemophilia Surveillance project

Zur Polarographie von Niob und Tantal

Clinical leaders' and staff's assessment of the current quality related to the patient pathways and expectations of and knowledge about accreditation--a baseline evaluation in Copenhagen County

The structure of H3O+TiF5

The phosphonium - sulfonium - and arsonium — salts of TaF6− and Ta2F11

Capturing daily assessments and home treatment of congenital hemophilia with inhibitors: design, disposition, and implications of the Dosing Observational Study in Hemophilia (DOSE)

Suchergebnisse filtern